Suppr超能文献

甲基丙二酸血症肾脏管理临床实践建议:来自ERKNet和MetabERN的专家共识声明

Clinical Practice Recommendations on Kidney Management in Methylmalonic Acidemia: an Expert Consensus Statement From ERKNet and MetabERN.

作者信息

Servais Aude, Zacchia Miriam, Dehoux Laurène, Shroff Rukshana, Brassier Anais, Taurisano Roberta, Kölker Stefan, Oh Jun, Ariceta Gema, Stojanovic Jelena, Hörster Friederike, Strologo Dello, Spada Marco, Schiff Manuel, Dionisi-Vici Carlo

机构信息

Nephrology and Transplantation Department, Inherited Kidney Diseases Reference Center, Necker-Enfants Malades University Hospital, Assistance Publique Hôpitaux de Paris, Inserm U1163, Imagine Institute, Université de Paris, Paris, France.

Department of Medical and Translational Sciences, University of Campania, Luigi Vanvitelli, Naples, Italy.

出版信息

Kidney Int Rep. 2024 Sep 6;9(12):3362-3374. doi: 10.1016/j.ekir.2024.09.002. eCollection 2024 Dec.

Abstract

Methylmalonic acidemias (MMAs) are rare inherited metabolic diseases with multiorgan involvement. Chronic kidney disease (CKD) is a common complication, leading to kidney failure, dialysis, and kidney transplantation (KT). The objective of these guidelines was to develop clinical practice recommendations focusing on specific aspects of the kidney management of this disease. Development of these clinical practice recommendations is an initiative of the European Reference Network for Rare Kidney Diseases in collaboration with the European Reference Network for Hereditary Metabolic Disorders and included pediatric and adult nephrologists, metabolic specialists, as well as liver and kidney transplant specialists. CKD has become a significant clinical issue that requires specific follow-up in both pediatric and adult departments. Creatinine-based formulae significantly overestimate kidney function and the estimation of estimated glomerular filtration rate (eGFR) is more accurate using cystatin C. Besides usual kidney indications, acute dialysis may be required in emergency in case of acute metabolic decompensation to clear metabolic toxins. Long-term dialysis may be initiated for clearance of toxic metabolites. Long hours on hemodialysis (HD) and/or daily dialysis are required. The indications for transplantation in MMA are a high rate of metabolic decompensations, a high burden of disease and difficult metabolic control. Transplantation is also indicated in case of long-term complications. Combined liver-kidney transplantation (LKT) should be preferred in patients with MMA with CKD. Possible calcineurin inhibitors (CNIs) induced neurotoxicity was described in patients with MMA requiring immunosuppressive treatment monitoring and adaptation. Overall, 13 statements were produced to provide guidance on the management of CKD, dialysis, and transplantation in pediatric and adult patients with MMA.

摘要

甲基丙二酸血症(MMAs)是一类罕见的累及多器官的遗传性代谢疾病。慢性肾脏病(CKD)是其常见并发症,可导致肾衰竭、透析及肾移植(KT)。这些指南的目的是制定针对该疾病肾脏管理特定方面的临床实践建议。这些临床实践建议由欧洲罕见肾脏病参考网络与欧洲遗传性代谢疾病参考网络合作制定,参与人员包括儿科和成人肾脏病专家、代谢专家以及肝肾移植专家。CKD已成为一个重要的临床问题,在儿科和成人科室均需要进行特殊随访。基于肌酐的公式会显著高估肾功能,使用胱抑素C估算估算肾小球滤过率(eGFR)更为准确。除了常见的肾脏指标外,在急性代谢失代偿的紧急情况下,可能需要进行急性透析以清除代谢毒素。为清除有毒代谢产物,可能需要启动长期透析。需要长时间进行血液透析(HD)和/或每日透析。MMA患者进行移植的指征包括代谢失代偿率高、疾病负担重以及代谢控制困难。长期并发症的情况下也建议进行移植。对于患有CKD的MMA患者,应优先考虑联合肝肾移植(LKT)。在需要免疫抑制治疗监测和调整的MMA患者中,已有关于钙调神经磷酸酶抑制剂(CNIs)可能诱发神经毒性的描述。总体而言,共制定了13条声明,为儿科和成人MMA患者的CKD、透析及移植管理提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8b3/11652068/ce2585d434ab/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验